+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensis



Inefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensis



Journal of Venomous Animals and Toxins including Tropical Diseases 13(3): 598-606



Pentavalent antimonial (Sb-V) is the first treatment for cutaneous leishmaniasis (CL). Other drugs present similar side effects and higher cost. Oral miltefosine is effective to treat kala-azar. The aim of the present study was to compare the efficacy of glucamine ( SbV) plus topical miltefosine with glucamine in the treatment of CL. Eighty isogenic C57BL/6 mice were inoculated with Leishmania (Leishmania) amazonensis and divided into two groups: one group was treated with SbV associated with miltefosine, and the other group received SbV plus saline solution. Groups were evaluated according to the diameter of the inoculated foot pad, the culture, and the parasite count using the limiting dilution assay. There was not statistical difference. The efficacy of glucamine in CL treatment did not increase when associated with topical miltefosine.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 016114409

Download citation: RISBibTeXText

DOI: 10.1590/s1678-91992007000300004


Related references

Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis. Revista Da Sociedade Brasileira de Medicina Tropical 41(4): 424-427, 2008

The use of azythromycin and N-methyl glucamine for the treatment of cutaneous Leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL6 mice. Anais Brasileiros de Dermatologia 84(2): 125-128, 2009

Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania amazonensis. Revista Da Sociedade Brasileira De Medicina Tropical: 4, 424-427, 2008

The association azithromycin, pentoxifylline and rifampicin is effective in the treatment of experimental cutaneous leishmaniasis caused by Leishmania Leishmania amazonensis in C57BL/6 mice. Revista Da Sociedade Brasileira De Medicina Tropical: Suplemento Iii, 202, 2008

In vivo Terbinafine inefficacy on cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL/6 mice. Revista Da Sociedade Brasileira de Medicina Tropical 36(4): 531-533, 2003

Draft Genome Sequences of Leishmania ( Leishmania ) amazonensis , Leishmania ( Leishmania ) mexicana , and Leishmania ( Leishmania ) aethiopica , Potential Etiological Agents of Diffuse Cutaneous Leishmaniasis. Microbiology Resource Announcements 8(20):, 2019

Study of the efficacy of N-methyl glucamine antimoniate (Sb V ) associated with photodynamic therapy using liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL6 mice. Photodiagnosis and Photodynamic Therapy 26: 261-269, 2019

Efficacies of Ky62 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous Leishmaniasis and Visceral Leishmaniasis. Antimicrobial Agents and Chemotherapy 42(10): 2542-2548, 1998

Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis. Antimicrobial Agents and ChemoTherapy 42(10): 2542-2548, 1998

Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis. Antimicrobial Agents and ChemoTherapy 54(11): 4699-4704, 2010

Leishmania (Leishmania) amazonensis: experimental cutaneous leishmaniasis associated with systemic amyloidosis in mice. Experimental Parasitology 120(1): 123-125, 2008

Action of pentoxifylline on experimental cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis. Memorias do Instituto Oswaldo Cruz 95(4): 477-482, 2000

Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. American Journal of Tropical Medicine and Hygiene 75(6): 1074-1077, 2006

Experimental cutaneous leishmaniasis. III. Histopathological aspects of the developmental behavior of the cutaneous lesion induced in Cebus apella (Primates: Cebidae) by Leishmania (Viannia) lainsoni, L. (V.) braziliensis and L. (Leishmania) amazonensis. Revista do Instituto de Medicina Tropical de Sao Paulo 32(6): 387-394, 1990

Evaluation of the efficacy of systemic miltefosine associated with photodynamic therapy with liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL/6 mice. Photodiagnosis and Photodynamic Therapy 13: 282-290, 2016